Itemization difference of patient-reported outcome in patients with chronic liver disease

PLoS One. 2022 Feb 22;17(2):e0264348. doi: 10.1371/journal.pone.0264348. eCollection 2022.

Abstract

Background and aims: The itemization difference of patient-reported outcome (PRO) in hepatitis patients with different etiologies remains elusive in Asia. We aimed to assess the characteristics and the difference of health-related quality of life (HRQoL) in chronic hepatitis B (CHB), chronic hepatitis C (CHC), and non-alcoholic fatty liver disease (NAFLD) patients.

Methods: We conducted the study in an outpatient setting. The 36-Item Short Form Health Survey (SF-36) was completed by the patients upon the initial diagnosis and recruitment for a long-term follow-up purpose. The PRO results were also assessed by disease severity.

Results: There were 244 patients (198 males) of CHB, 54 patients (29 males) of CHC, and 129 patients (85 males) of NAFLD, respectively. CHC patient had the mean score of 67.1 ± 23.3 in physical component summary (PCS) of the SF-36 health survey, which was significantly lower than CHB patients (76.4 ± 19.5), and NAFLD patients (77.5 ± 13.7), respectively (p = 0.001). The significantly lower performance of PCS in CHC patients was mainly attributed to the lower performance in physical functioning and bodily pain components. Higher fibrosis 4 index scores were significantly associated with lower PCS scores in all patient groups. There was no significant difference of mean mental component summary (MCS) between groups. However, NAFLD patients had significantly lower mental health scores than other groups (p = 0.02).

Conclusions: The significant difference of HRQoL exists in hepatitis patients with different etiologies. Disease severity leads to a lower PCS performance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Hepatitis B, Chronic / psychology
  • Hepatitis B, Chronic / therapy*
  • Hepatitis C, Chronic / psychology
  • Hepatitis C, Chronic / therapy*
  • Humans
  • Liver Cirrhosis / psychology
  • Liver Cirrhosis / therapy*
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / psychology
  • Non-alcoholic Fatty Liver Disease / therapy*
  • Patient Reported Outcome Measures*
  • Quality of Life

Grants and funding

This study was supported partly by grant from Kaohsiung Medical University (grant number 97CM-KMU for the author Jee-Fu Huang) and Kaohsiung Medical University Hospital (grant number SA10907 for the author Jee-Fu Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.